---
title: "Medtronic plc (MDT.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/MDT.US.md"
symbol: "MDT.US"
name: "Medtronic plc"
industry: "Health Care Equipment"
datetime: "2026-04-16T07:46:10.109Z"
locales:
  - [en](https://longbridge.com/en/quote/MDT.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MDT.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MDT.US.md)
---

# Medtronic plc (MDT.US)

## Company Overview

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | US Market |
| Website | [www.medtronic.com](https://www.medtronic.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-04-16T04:30:17.000Z

**Overall: C (0.43)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 42 / 182 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Large - The company has stable operations, allowing for dependable long-term returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 6.88% |  |
| Net Profit YoY | 8.29% |  |
| P/B Ratio | 2.28 |  |
| Dividend Ratio | 3.26% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 111826380364.40 |  |
| Revenue | 35484000000.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 9.38% | B |
| Profit Margin | 13.00% | B |
| Gross Margin | 64.82% | A |
| Revenue YoY | 6.88% | C |
| Net Profit YoY | 8.29% | C |
| Total Assets YoY | 1.68% | C |
| Net Assets YoY | -0.84% | D |
| Cash Flow Margin | 157.92% | B |
| OCF YoY | 6.88% | C |
| Turnover | 0.39 | C |
| Gearing Ratio | 46.23% | C |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Medtronic plc",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "6.88%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "8.29%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "2.28",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "3.26%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "111826380364.40",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "35484000000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "9.38%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "13.00%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "64.82%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "6.88%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "8.29%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "1.68%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "-0.84%",
          "rating": "D"
        },
        {
          "name": "Cash Flow Margin",
          "value": "157.92%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "6.88%",
          "rating": "C"
        },
        {
          "name": "Turnover",
          "value": "0.39",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "46.23%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 24.24 | 17/182 | 26.79 | 25.55 | 24.40 |
| PB | 2.28 | 62/182 | 2.60 | 2.47 | 2.29 |
| PS (TTM) | 3.15 | 74/182 | 3.62 | 3.49 | 3.27 |
| Dividend Yield | 3.26% | 2/182 | 3.25% | 3.03% | 2.88% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Delcath (DCTH.US) | C | A | B | A | A | A |
| 02 | Abbott Laboratories (ABT.US) | B | C | C | C | B | B |
| 03 | Intuitive Surgical (ISRG.US) | A | B | C | A | B | B |
| 04 | Stryker (SYK.US) | A | B | C | C | B | B |
| 05 | Boston Scientific (BSX.US) | B | B | C | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-04-15T04:00:00.000Z

Total Analysts: **31**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 14 | 45% |
| Overweight | 4 | 13% |
| Hold | 12 | 39% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 87.10 |
| Highest Target | 125.00 |
| Lowest Target | 91.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/MDT.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/MDT.US/norm.md)
- [Related News](https://longbridge.com/en/quote/MDT.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/MDT.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**